A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone
Clinical trial NCT04158947 · UNKNOWN
Trial details
- NCT number
- NCT04158947
- Sponsor
- xuexin he
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-10
- Primary completion
- 2023-12-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.